
Six TransCelerate Member Companies formed BioCelerate, a subsidiary to focus on identifying innovative solutions for operational challenges in the preclinical space.
Six TransCelerate Member Companies formed BioCelerate, a subsidiary to focus on identifying innovative solutions for operational challenges in the preclinical space.
The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs.
Sponsors now take different approaches for “regulatory” trials to gain market registration, and “real world” studies to determine how a product should be used in practice, but these two worlds should not be separate.
Use the “CLEAR” path to effectively engage patients and build their confidence in an increasingly digital and mobile pharmaceutical environment.
The eClinical division of Merge Healthcare, an IBM company, will continue to participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.
A recent survey by Worldwide Clinical Trials showed coordinators' are concerned eCOA interferes with normal patient rapport.
ACS and Quintiles will build a comprehensive and integrated clinical registry platform that combines data from more than 1,800 hospitals across the United States, international medical contributors and individual surgeons to improve surgical patient care outcomes.
Nonclinical models are limited, and clinical trials are challenging because, among many factors, is that pain is subjective, making it hard to define objective endpoints or to compare one drug to another.
The collaboration will allow joint customers to securely combine data from all site-facing applications using single sign-on with non-site facing data sources.
The contract negotiation process is generally believed to be the primary bottleneck in site startup and MAGI's CTA template would help that process.
The addition of Research Across America's sites means that Synexus can now offer extra capacity, particular U.S. market expertise and therapeutic experience.
R&G provides a full range of clinical trial services for both domestic and global partners.
Networks will encourage their participant members to share their health information with researchers to support studies that have been identified as highly relevant and useful by network members.
Friends of Cancer Research is urging Congress to encourage FDA to adopt a new “disease-oriented” approach biomedical regulation, and for FDA to formulate a pilot to test this approach.
The late phase respiratory and cardiac safety study will involve 14,000 patients across 750 sites, the company's largest such trial in its history.
INC Research becomes the Society for Clinical Research Sites' inaugural "Circle of Innovation" sponsor, with a focus on enhancing site support globally.
The Center for Information and Study on Clinical Research Participation is launching its first international event, where in Europe, CISCRP says, patient involvement in clinical trials is waning and general awareness about research opportunities is low.
Applied Clinical Trials presents the latest issues that have risen to prominence since RBM adoption grows. This edition presents a well-rounded look at RBM including articles that describe current RBM trends; a survey of European CRAs, which shows the difficulties among sites and monitors with RBM; a comprehensive look at how sponsors and CROs can support their employees in the RBM transition, and closes with a case study on Novartis' use of adaptive monitoring.